Arix Bioscience plc announces participation at the 19th Annual Rodman & Renshaw Global Investment Conference in New York City on 10-12 September 2017

8th September 2017

LONDON, 8 September 2017:

Arix Bioscience plc (LSE: ARIX) (“Arix Bioscience”, or “the Company”), a global healthcare and life science company supporting medical innovation, will present at the 19th Annual Rodman & Renshaw Global Investment Conference, sponsored by H.C. Wainwright & Co., LLC. The conference is being held on 10-12 September 2017 at the Lotte New York Palace Hotel in New York City, and the Arix Bioscience presentation is on 12 September at 10:00am Eastern time / 3:00pm BST.

Jonathan Peacock, Chairman of Arix Bioscience, will provide an overview of the Company’s business during the live presentation and will participate in one-on-one meetings with investors who are registered to attend the conference.

The presentation will be webcast live. To access the webcast, please visit http://wsw.com/webcast/rrshq27/arix/index.aspx. The webcast replay will remain available for 90 days following the live presentation.